Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$86.25
-1.1%
$103.25
$86.15
$139.06
$151.83B0.6513.65 million shs12.45 million shs
Accuray Incorporated stock logo
ARAY
Accuray
$0.48
+3.5%
$0.44
$0.33
$2.10
$54.74M1.431.18 million shs1.68 million shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$451.73
+0.1%
$473.00
$427.84
$603.88
$159.86B1.512.29 million shs1.98 million shs
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
$0.81
-5.8%
$0.92
$0.78
$2.10
$33.90M1.65201,247 shs862,167 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-2.61%-7.06%-15.23%-19.42%-34.22%
Accuray Incorporated stock logo
ARAY
Accuray
-1.26%+6.40%+10.96%-39.10%-64.82%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
-1.40%-3.27%-0.15%-5.67%-15.13%
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
-3.14%-3.34%-10.10%-16.48%-27.71%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$86.25
-1.1%
$103.25
$86.15
$139.06
$151.83B0.6513.65 million shs12.45 million shs
Accuray Incorporated stock logo
ARAY
Accuray
$0.48
+3.5%
$0.44
$0.33
$2.10
$54.74M1.431.18 million shs1.68 million shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$451.73
+0.1%
$473.00
$427.84
$603.88
$159.86B1.512.29 million shs1.98 million shs
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
$0.81
-5.8%
$0.92
$0.78
$2.10
$33.90M1.65201,247 shs862,167 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-2.61%-7.06%-15.23%-19.42%-34.22%
Accuray Incorporated stock logo
ARAY
Accuray
-1.26%+6.40%+10.96%-39.10%-64.82%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
-1.40%-3.27%-0.15%-5.67%-15.13%
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
-3.14%-3.34%-10.10%-16.48%-27.71%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.88
Moderate Buy$119.4338.47% Upside
Accuray Incorporated stock logo
ARAY
Accuray
2.00
Hold$2.00319.29% Upside
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
2.65
Moderate Buy$581.9128.82% Upside
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
2.00
Hold$2.00146.91% Upside

Current Analyst Ratings Breakdown

Latest ARAY, RMTI, ISRG, and ABT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/27/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Reiterated RatingBuy$131.00
4/24/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
DowngradeHold (C)Hold (C-)
4/23/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Set Price TargetOverweight$712.00 ➝ $651.00
4/22/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
DowngradeOutperformNeutral$92.00
4/22/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Lower Price TargetBuy$653.00 ➝ $604.00
4/22/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Boost Price TargetOutperform$575.00 ➝ $610.00
4/22/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Boost Price TargetBuy$609.00 ➝ $621.00
4/22/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Lower Price TargetHold$560.00 ➝ $515.00
4/22/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Lower Price TargetOutperform$615.00 ➝ $577.00
4/22/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Lower Price TargetOutperform$622.00 ➝ $573.00
4/22/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Lower Price TargetOverweight$625.00 ➝ $550.00
(Data available from 5/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$44.33B3.39$6.92 per share12.47$30.26 per share2.85
Accuray Incorporated stock logo
ARAY
Accuray
$458.51M0.12$0.05 per share10.34$0.72 per share0.66
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$10.06B15.90$9.29 per share48.65$49.69 per share9.09
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
$69.26M0.46N/AN/A$0.94 per share0.86
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$6.52B$3.5724.1614.231.4513.90%17.62%10.01%7/16/2026 (Estimated)
Accuray Incorporated stock logo
ARAY
Accuray
-$1.59M-$0.29N/AN/AN/A-8.15%-59.81%-7.91%5/6/2026 (Estimated)
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.86B$8.2554.7646.053.6128.15%15.98%14.07%N/A
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
-$5.31M-$0.15N/A20.25N/A-7.67%-15.64%-9.61%5/7/2026 (Confirmed)

Latest ARAY, RMTI, ISRG, and ABT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2026Q1 2026
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
-$0.01N/AN/AN/A$17.95 millionN/A
5/6/2026Q3 2026
Accuray Incorporated stock logo
ARAY
Accuray
-$0.05-$0.09-$0.04-$0.09$111.90 million$104.85 million
4/21/2026Q1 2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.08$2.50+$0.42$2.28$2.62 billion$2.77 billion
4/16/2026Q1 2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.14$1.15+$0.01$0.61$10.99 billion$11.16 billion
3/26/2026Q4 2025
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
$0.04-$0.01-$0.05-$0.01$18.58 million$18.35 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.522.92%+10.39%70.59%54 Years
Accuray Incorporated stock logo
ARAY
Accuray
N/AN/AN/AN/AN/A
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/AN/AN/AN/AN/A
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
N/AN/AN/AN/AN/A

Latest ARAY, RMTI, ISRG, and ABT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/20/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.632.48%4/15/20264/15/20265/15/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.56
1.39
1.01
Accuray Incorporated stock logo
ARAY
Accuray
2.34
1.47
0.71
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/A
4.61
3.59
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
0.25
3.98
3.63

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Accuray Incorporated stock logo
ARAY
Accuray
64.08%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
83.64%
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
23.31%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
Accuray Incorporated stock logo
ARAY
Accuray
4.36%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.60%
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
3.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.74 billion1.73 billionOptionable
Accuray Incorporated stock logo
ARAY
Accuray
1,040118.78 million113.60 millionOptionable
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
17,021354.16 million352.04 millionOptionable
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
30039.40 million37.99 millionOptionable

Recent News About These Companies

Rockwell Medical, Inc. Q4 2025 Earnings Call Summary
Rockwell Medical Q4 Earnings Preview

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$86.25 -0.92 (-1.05%)
Closing price 03:59 PM Eastern
Extended Trading
$86.43 +0.18 (+0.21%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Accuray stock logo

Accuray NASDAQ:ARAY

$0.48 +0.02 (+3.52%)
Closing price 04:00 PM Eastern
Extended Trading
$0.40 -0.08 (-16.77%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

Intuitive Surgical stock logo

Intuitive Surgical NASDAQ:ISRG

$451.73 +0.35 (+0.08%)
Closing price 04:00 PM Eastern
Extended Trading
$451.18 -0.55 (-0.12%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Rockwell Medical stock logo

Rockwell Medical NASDAQ:RMTI

$0.81 -0.05 (-5.85%)
Closing price 04:00 PM Eastern
Extended Trading
$0.81 0.00 (0.00%)
As of 06:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.